Eric Romanowski

Mr. Eric Romanowski

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2005 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
EREric Romanowski
Eric Romanowski
FMFrancis S. Mah
Francis S. Mah
KYKathleen A. Yates
Kathleen A. Yates
RKRegis P. Kowalski
Regis P. Kowalski
YGY. Jerold Gordon
Y. Jerold Gordon

1 May 2006 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Closed access
PDF file
EREric Romanowski
Eric Romanowski
KYKathleen A. Yates
Kathleen A. Yates
BTBarbara Teuchner
Barbara Teuchner
MNMarkus Nagl
Markus Nagl
EIEveline U. Irschick
Eveline U. Irschick
YGY. Jerold Gordon
Y. Jerold Gordon
Purpose. To determine whether N-chlorotaurine (NCT) demonstrates antiviral activity against adenovirus (Ad) in vitro and in the Ad5/NZW rabbit ocular model.

1 January 2005 in Cornea
Verified
Journal Article
Closed access
EREric Romanowski
Eric Romanowski
PPPatricia Pless
Patricia Pless
KYKathleen A Yates
Kathleen A Yates
YGY Jerold Gordon
Y Jerold Gordon
To determine the effects of topical cyclosporine A (CsA), an immunomodulating T-cell inhibitor, on the formation of subepithelial immune corneal infiltrates (SEIs) and acute adenovirus replication in the NZW Rabbit Ad5 SEI and Ad5 replication models. In the Ad5 SEI model, eyes were treated topically with either 2% CsA in corn oil, 0.5% CsA in artificial tears, or their respective control vehicles 4 times daily for 14 days and then twice daily for 4 days. SEIs were graded on day 23 by masked slit-lamp examination. Using the same treatment protocol in the Ad5 replication model, rabbit eyes were cultured on days 0, 1, 3, 4, 5, 7, 9, 11, 14, 16, 18, and 21 postinoculation, and their tear film viral titers were determined on A549 cells. The formation of SEIs was significantly reduced following treatment with either 2.0% or 0.5% CsA. However, 2% and 0.5% CsA significantly increased viral titers on several days, prolonged the duration of Ad5 shedding, and increased the number of Ad5-positive cultures per total during the late phase of infection (days 7–21) compared with their respective controls. The 0.5% CsA was equipotent to 2% CsA for most outcome parameters tested. A role for topical CsA in the treatment of adenovirus ocular infections remains to be defined in large, randomized controlled clinical trials. During acute infection, reducing SEI formation is highly desirable, but enhancing viral replication may inadvertently serve to promote local epidemics. Future trials should address the important issues of optimized formulation and dose regimen and the possibility of prolonging virus shedding.

1 April 2013 in JAMA Ophthalmology
Verified
Journal Article
Closed access
EREric Romanowski
Eric Romanowski
KYKathleen A. Yates
Kathleen A. Yates
KOKatherine E. O’connor
Katherine E. O’connor
FMFrancis S. Mah
Francis S. Mah
RSRobert M. Q. Shanks
Robert M. Q. Shanks
RKRegis P. Kowalski
Regis P. Kowalski
Swimming pools can be a vector for transmission of adenovirus ocular infections. Polyhexamethylene biguanide (PHMB) is a disinfectant used in swimming pools and hot tubs. To determine whether PHMB is an effective disinfectant against ocular adenovirus serotypes at a concentration used to disinfect swimming pools and hot tubs. In vitro laboratory study. The direct disinfecting activity of PHMB was determined in triplicate assays by incubating 9 human adenovirus types (1, 2, 3, 4, 5, 7a, 8, 19, and 37) with PHMB concentrations of 50 and 0 ppm (micrograms per milliliter) for 24 hours at room temperature to simulate swimming pool temperatures or 40oC to simulate hot tub temperatures. Plaque assays were performed to determine adenovirus titers after incubation. Titers were log10 converted and mean (SD) log10 reductions relative to controls were calculated. Virucidal (>99.9%) decreases in mean adenovirus titers after PHMB treatment were determined for each adenovirus type and temperature tested. RESULTS At room temperature, 50 ppm of PHMB produced mean reductions in titers less than 1 log10 for all adenovirus types tested. At 40°C, 50 ppm of PHMB produced mean reductions in titers less than 1 log10 for 2 adenovirus types and greater than 1 but less than 3 log10 for 7 of 9 adenovirus types. At a concentration of 50 ppm, PHMB was not virucidal against adenovirus at temperatures consistent with swimming pools or hot tubs. Recreational water maintained and sanitized with PHMB can serve as a vector for the transmission of ocular adenovirus infections.

1 January 2019 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
ADAsad F. Durrani
Asad F. Durrani
SFSamuel C. Faith
Samuel C. Faith
RKRegis P. Kowalski
Regis P. Kowalski
MYMarco Yu
Marco Yu
EREric Romanowski
Eric Romanowski
Vishal JhanjiVishal Jhanji
Vishal Jhanji

1 November 2009 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Closed access
PDF file
EREric Romanowski
Eric Romanowski
KYKathleen A. Yates
Kathleen A. Yates
YGY. Jerold Gordon
Y. Jerold Gordon
Purpose.: To evaluate the antiviral activity of 2′, 3′-dideoxycytidine (ddC) in vitro against a panel of ocular adenovirus serotypes and in vivo in the ocular Ad5/NZW rabbit replication model. Methods.: In vitro, the 50% inhibitory concentrations (IC50) of ddC and cidofovir were determined using standard plaque-reduction assays. In vivo, 40 rabbits were topically inoculated in both eyes with Ad5 after corneal scarification. On day 1, the rabbits were equally divided into four topical treatment groups: 3% ddC; 2% ddC; 0.5% cidofovir; and saline. ddC and saline eyes were treated four times daily for 7 days, and cidofovir-treated eyes were treated twice daily for 7 days. Eyes were cultured for virus a multiple times over 2 weeks. Results.: The in vitro IC50 for ddC ranged from 0.18 to 1.85 μg/mL, whereas those for cidofovir ranged from 0.018 to 5.47 μg/mL. ddC was more potent than cidofovir for seven of nine serotypes. In vivo, 3% ddC, 2% ddC, and 0.5% cidofovir significantly reduced the number of Ad5-positive cultures per total (days 1–14), mean Ad5 ocular titer (days 1–5), and duration of shedding (among other outcome measures) compared with the saline control. The 3% and 2% ddC treatments were significantly more efficacious than the 0.5% cidofovir treatment in the parameters listed above. Conclusions.: ddC demonstrated potent antiadenovirus activity in vitro and in vivo. Systemic safety studies after topical ocular administration are needed to evaluate ddC as a topical antiviral treatment for adenoviral ocular infections in the target population.